Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INGEVITY CORPORATION

(NGVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ingevity : Says it Plans to Challenge Jury Decision on Emissions Control Patent, Anticompetitive Practices

09/16/2021 | 07:40am EDT


© MT Newswires 2021
All news about INGEVITY CORPORATION
10/13INGEVITY : Plans to Increase Total Monomer Production Capacity by More Than 20%
MT
10/13INGEVITY : increases caprolactone monomer capacity at its Warrington, UK facility
BU
10/13Ingevity Corporation Increases Caprolactone Monomer Capacity At Its Warrington, UK Faci..
CI
09/30INGEVITY : announces dates for third quarter earnings release and webcast
BU
09/27INGEVITY : receives 2021 Candidate Experience Award
PU
09/16INGEVITY : Says it Plans to Challenge Jury Decision on Emissions Control Patent, Anticompe..
MT
09/16INGEVITY : to challenge jury verdict on emissions control patent (Form 8-K)
PU
09/16INGEVITY CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/16INGEVITY : to challenge jury verdict on emissions control patent
BU
09/16BASF : Wins $28 Million in Damages in Antitrust Action Against Ingevity
MT
More news
Analyst Recommendations on INGEVITY CORPORATION
More recommendations
Financials (USD)
Sales 2021 1 352 M - -
Net income 2021 202 M - -
Net Debt 2021 879 M - -
P/E ratio 2021 15,7x
Yield 2021 -
Capitalization 3 072 M 3 072 M -
EV / Sales 2021 2,92x
EV / Sales 2022 2,69x
Nbr of Employees 1 750
Free-Float 91,6%
Chart INGEVITY CORPORATION
Duration : Period :
Ingevity Corporation Technical Analysis Chart | NGVT | US45688C1071 | MarketScreener
Technical analysis trends INGEVITY CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 77,73 $
Average target price 97,13 $
Spread / Average Target 25,0%
EPS Revisions
Managers and Directors
John C. Fortson President, CEO, Treasurer & Director
Mary Dean Hall Chief Financial Officer & Executive Vice President
Jean Stuart Blackwell Chairman
Marty Heyne Senior Vice President-Operations
Luis Fernandez-Moreno Independent Director
Sector and Competitors